These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36995338)

  • 1. Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes : an in vitro and in vivo study.
    Chen Z; Cheng Z; Tang Z; Li M; Tang X; Zhang H; Sun L
    Clin Exp Rheumatol; 2023 Nov; 41(11):2151-2161. PubMed ID: 36995338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
    Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH
    Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Wen H; Liu Y; Li J; Wei D; Liu D; Zhao F
    Clin Exp Rheumatol; 2018; 36(5):798-805. PubMed ID: 29465363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
    Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H
    Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human endostatin inhibits TNF-alpha-induced receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes in mice with adjuvant arthritis.
    Gao QF; Zhang XH; Yuan FL; Zhao MD; Li X
    Cell Biol Int; 2016 Dec; 40(12):1340-1348. PubMed ID: 27730697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.
    Kim JY; Lee EY; Lee EB; Lee YJ; Yoo HJ; Choi J; Song YW
    Arthritis Res Ther; 2012 Aug; 14(4):R187. PubMed ID: 22901757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Wang XT; Li P; Xu TS; Ding R; Zhang X; Bi LQ
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):44-50. PubMed ID: 27894399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.
    Li Y; Li D; Li Y; Wu S; Jiang S; Lin T; Xia L; Shen H; Lu J
    Osteoporos Int; 2016 Apr; 27(4):1537-1546. PubMed ID: 26572759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of fibroblast-like synoviocytes in rheumatoid arthritis was impaired by dickkopf-1 targeting siRNA.
    Liu YY; Wang SY; Li YN; Bian WJ; Zhang LQ; Li YH; Long L; Liu X; Zhang XW; Li ZG
    Chin Med J (Engl); 2020 Mar; 133(6):679-686. PubMed ID: 32068606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH
    J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
    Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
    Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
    Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
    Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA Promotes Synovial Proliferation and Bone Erosion in Rheumatoid Arthritis through Wnt/PCP Pathway.
    Chen N; Diao CY; Huang X; Tan WX; Chen YB; Qian XY; Gao J; Zhao DB
    Mediators Inflamm; 2023; 2023():5057009. PubMed ID: 38022686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.